home / open_comments

documents

Federal regulatory documents currently open for public comment.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

79 rows where agency_id = "FDA" sorted by comment_end_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_year, posted_month, comment_end_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

document_type 3

  • Notice 67
  • Other 8
  • Proposed Rule 4

agency_id 1

  • FDA · 79 ✖
id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date ▲ last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-N-0131-0001 FDA FDA-2026-N-0131 FDA Rare Disease Innovation Hub Future Programming; Request for Comments Notice Request for Comments 2026-01-30 2026 1 2026-01-30 2027-01-01 2026-05-05 09:00:20 2026-01903 1 0 09000064b91893ee
FDA-2016-D-1280-0005 FDA FDA-2016-D-1280 Electronic Submission of Postmarketing Individual Case Safety Reports to the Food and Drug Administration Adverse Event Monitoring System Using International Council of Harmonisation E2B(R3) Data Standards; Regional Data Elements and Implementation Schedule Notice Announcement 2026-04-06 2026 4 2026-04-06 2026-10-02 2026-04-07 09:00:25 2026-06660 1 0 09000064b9253dbc
FDA-2025-E-2426-0006 FDA FDA-2025-E-2426 Determination of Regulatory Review Period for Purposes of Patent Extension; BLUJEPA Notice Determinations 2026-02-13 2026 2 2026-02-13 2026-08-13 2026-02-13 20:03:13 2026-02901 1 0 09000064b91aa6fb
FDA-2025-E-0152-0006 FDA FDA-2025-E-0152 Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY Notice Determinations 2026-02-06 2026 2 2026-02-06 2026-08-06 2026-02-06 20:05:43 2026-02388 1 0 09000064b919467e
FDA-2025-E-0153-0006 FDA FDA-2025-E-0153 Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY Notice Determinations 2026-02-06 2026 2 2026-02-06 2026-08-06 2026-02-06 20:06:34 2026-02388 1 0 09000064b919467f
FDA-2024-E-3539-0006 FDA FDA-2024-E-3539 Determination of Regulatory Review Period for Purposes of Patent Extension; BEQVEZ Notice Determinations 2026-02-06 2026 2 2026-02-06 2026-08-06 2026-02-14 13:19:52 2026-02387 1 0 09000064b9195b4d
FDA-2025-E-0154-0006 FDA FDA-2025-E-0154 Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY Notice Determinations 2026-02-06 2026 2 2026-02-06 2026-08-06 2026-02-06 20:07:01 2026-02388 1 0 09000064b9195c17
FDA-2026-N-3273-0001 FDA FDA-2026-N-3273 Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments; Public Meeting; Request for Comments Notice Request for Comments 2026-04-15 2026 4 2026-04-15 2026-07-24 2026-04-15 17:05:22 2026-07248 1 0 09000064b9282224
FDA-2025-N-6895-0001 FDA FDA-2025-N-6895 Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments—Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List Notice Request for Comments 2026-04-16 2026 4 2026-04-16 2026-07-23 2026-05-17 09:00:23 2026-07361 1 0 09000064b92865ab
FDA-2026-P-0749-0001 FDA FDA-2026-P-0749 Citizen Petition from Apotex Inc. Other Citizen Petition 2026-01-26 2026 1 2026-01-26 2026-07-23 2026-05-08 20:03:22   1 0 09000064b9182c73
FDA-2026-D-1255-0002 FDA FDA-2026-D-1255 Safety Assessment of Genome Editing in Human Gene Therapy Products Using Next-Generation Sequencing; Draft Guidance for Industry Other Guidance 2026-04-15 2026 4 2026-04-15 2026-07-15 2026-05-15 09:00:20   1 0 09000064b9282a2a
FDA-2026-N-4126-0001 FDA FDA-2026-N-4126 Azodicarbonamide (ADA); Request for Information Notice Requests for Information (RFI) 2026-05-13 2026 5 2026-05-13 2026-07-14 2026-05-13 17:13:38 2026-09508 1 0 09000064b92d17fd
FDA-2026-N-3098-0001 FDA FDA-2026-N-3098 Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting Notice 60 Day Proposed Information Collection 2026-05-13 2026 5 2026-05-13 2026-07-14 2026-05-13 16:56:28 2026-09543 1 0 09000064b92d4966
FDA-2026-N-2526-0001 FDA FDA-2026-N-2526 Butylated Hydroxytoluene (BHT); Request for Information Notice Requests for Information (RFI) 2026-05-13 2026 5 2026-05-13 2026-07-14 2026-05-13 17:01:00 2026-09507 1 0 09000064b92d4931
FDA-2026-N-0005-0001 FDA FDA-2026-N-0005 Biomarker Incubator: Urinary Kidney Safety Biomarkers; Request for Information Notice Requests for Information (RFI) 2026-05-13 2026 5 2026-05-13 2026-07-14 2026-05-13 17:06:21 2026-09533 1 0 09000064b92d48f3
FDA-2023-N-0119-0020 FDA FDA-2023-N-0119 Fiscal Year 2026 Generic Drug Science and Research Initiatives Workshop; Public Workshop; Request for Comments Notice Request for Comments 2026-02-27 2026 2 2026-02-27 2026-07-11 2026-04-14 09:00:18 2026-03961 1 0 09000064b91e326c
FDA-2026-N-3070-0001 FDA FDA-2026-N-3070 Agency Information Collection Activities; Proposed Collection; Comment Request; National Youth Tobacco Survey Notice 60 Day Proposed Information Collection 2026-05-04 2026 5 2026-05-04 2026-07-07 2026-05-04 19:19:25 2026-08604 1 0 09000064b92c115c
FDA-2018-N-3240-0377 FDA FDA-2018-N-3240 List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act Notice Request for Comments 2026-05-01 2026 5 2026-05-01 2026-07-01 2026-05-17 09:00:24 2026-08552 1 0 09000064b92bb724
FDA-2026-N-3499-0001 FDA FDA-2026-N-3499 Obesity and Drug Dosing: Clinical Pharmacology Considerations; Request for Comments Notice Request for Comments 2026-05-01 2026 5 2026-05-01 2026-07-01 2026-05-02 09:00:17 2026-08521 1 0 09000064b92bb7fb
FDA-2026-N-3947-0001 FDA FDA-2026-N-3947 Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket; Request for Information and Comments Notice Request for Comments 2026-05-01 2026 5 2026-05-01 2026-07-01 2026-05-09 09:00:22 2026-08524 1 0 09000064b92bb6d7
FDA-2026-N-4268-0001 FDA FDA-2026-N-4268 Medical Devices; Exemptions From Premarket Notification: Certain Class II Devices; Request for Comments Notice Request for Comments 2026-05-01 2026 5 2026-05-01 2026-07-01 2026-05-09 09:00:22 2026-08499 1 0 09000064b92bb7b3
FDA-2026-N-3532-0001 FDA FDA-2026-N-3532 Agency Information Collection Activities; Proposed Collection; Comment Request; Good Laboratory Practice Requirements for Nonclinical Laboratory Studies Notice 60 Day Proposed Information Collection 2026-04-30 2026 4 2026-04-30 2026-06-30 2026-05-02 09:00:17 2026-08371 1 0 09000064b92b7fb3
FDA-2026-N-2366-0001 FDA FDA-2026-N-2366 Commissioner’s National Priority Voucher (CNPV) Pilot Program; Public Hearing; Request for Comments Notice Request for Comments 2026-03-23 2026 3 2026-03-23 2026-06-30 2026-05-01 09:00:14 2026-05573 1 0 09000064b922c21a
FDA-2026-N-1321-0001 FDA FDA-2026-N-1321 ChemoCentryx, Inc.; Proposal To Withdraw Approval of New Drug Application for TAVNEOS (Avacopan) Capsule, 10 Milligrams; Opportunity for a Hearing Notice Withdrawal 2026-04-30 2026 4 2026-04-30 2026-06-30 2026-05-16 09:00:16 2026-08455 1 0 09000064b92b7e81
FDA-2025-D-6130-0002 FDA FDA-2025-D-6130 Establishing Impurity Specifications for Antibiotics; Draft Guidance for Industry Other Guidance 2026-04-20 2026 4 2026-04-20 2026-06-23 2026-04-28 09:00:28   1 0 09000064b92940ac
FDA-2025-D-7121-0002 FDA FDA-2025-D-7121 Compliance Policy Regarding Premarket and Other Requirements for Certain NIOSH Approved Air-Purifying Respirators; Draft Guidance for Industry and Food and Drug Administration Staff Other Guidance 2026-04-20 2026 4 2026-04-20 2026-06-23 2026-05-06 09:00:15   1 0 09000064b928d63f
FDA-2026-N-2917-0001 FDA FDA-2026-N-2917 Agency Information Collection Activities; Proposed Collection; Comment Request; Generic Clearance for Qualitative Data To Support Social and Behavioral Research for Food, Dietary Supplements, Cosmetics, and Animal Food and Feed Notice 60 Day Proposed Information Collection 2026-04-17 2026 4 2026-04-17 2026-06-17 2026-04-17 16:47:09 2026-07501 1 0 09000064b9289353
FDA-2026-N-3099-0001 FDA FDA-2026-N-3099 Agency Information Collection Activities; Proposed Collection; Comment Request; Radioactive Drug Research Committees Notice 60 Day Proposed Information Collection 2026-04-17 2026 4 2026-04-17 2026-06-17 2026-04-17 16:55:18 2026-07507 1 0 09000064b9289303
FDA-2025-E-0501-0006 FDA FDA-2025-E-0501 Determination of Regulatory Review Period for Purposes of Patent Extension; UNLOXCYT Notice Determinations 2026-04-16 2026 4 2026-04-16 2026-06-16 2026-04-16 17:49:56 2026-07422 1 0 09000064b928671f
FDA-2021-D-0613-0003 FDA FDA-2021-D-0613 Stability Testing for Medicated Premixes (Revision 1); VICH GL8(R); Guidance for Industry; Draft Guidance; #91 Other Guidance 2026-04-16 2026 4 2026-04-16 2026-06-16 2026-04-16 20:09:33   1 0 09000064b9287b2e
FDA-2025-E-0502-0006 FDA FDA-2025-E-0502 Determination of Regulatory Review Period for Purposes of Patent Extension; UNLOXCYT Notice Determinations 2026-04-16 2026 4 2026-04-16 2026-06-16 2026-04-16 17:53:26 2026-07422 1 0 09000064b9286364
FDA-2026-N-3400-0001 FDA FDA-2026-N-3400 Agency Information Collection Activities; Proposed Collection; Comment Request; Orphan Drugs Notice 60 Day Proposed Information Collection 2026-04-16 2026 4 2026-04-16 2026-06-16 2026-04-18 09:00:22 2026-07423 1 0 09000064b9286561
FDA-2026-N-3240-0001 FDA FDA-2026-N-3240 Agency Information Collection Activities; Proposed Collection; Comment Request; Importation of Prescription Drugs Notice 60 Day Proposed Information Collection 2026-04-16 2026 4 2026-04-16 2026-06-16 2026-04-16 18:04:30 2026-07421 1 0 09000064b92866e7
FDA-2025-N-1600-0003 FDA FDA-2025-N-1600 Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; The Real Cost Campaign Outcomes Evaluation Study: Cohort 3 Notice 30 Day Proposed Information Collection 2026-05-13 2026 5 2026-05-13 2026-06-13 2026-05-13 17:17:21 2026-09448 1 0 09000064b92d4828
FDA-2026-N-4492-0001 FDA FDA-2026-N-4492 Drug Repurposing for Unmet Medical Needs; Request for Information Notice Requests for Information (RFI) 2026-05-12 2026 5 2026-05-12 2026-06-12 2026-05-17 09:00:25 2026-09366 1 0 09000064b92d15f4
FDA-2026-N-2742-0001 FDA FDA-2026-N-2742 Agency Information Collection Activities; Proposed Collection; Comment Request; Color Additive Certification Notice 60 Day Proposed Information Collection 2026-04-10 2026 4 2026-04-10 2026-06-10 2026-04-10 18:01:37 2026-06936 1 0 09000064b926825a
FDA-2026-N-2743-0001 FDA FDA-2026-N-2743 Agency Information Collection Activities; Proposed Collection; Comment Request; Submission of Petitions: Food Additive, Color Additive (Including Labeling), Submission of Information to a Master File in Support of Petitions; and Electronic Submission Using Food and Drug Administration Form 3503 Notice 60 Day Proposed Information Collection 2026-04-10 2026 4 2026-04-10 2026-06-10 2026-04-20 09:00:32 2026-06935 1 0 09000064b926821b
FDA-2026-N-2915-0001 FDA FDA-2026-N-2915 Agency Information Collection Activities; Proposed Collection; Comment Request; Premarket Approval of Medical Devices Notice 60 Day Proposed Information Collection 2026-04-10 2026 4 2026-04-10 2026-06-10 2026-04-10 17:47:50 2026-06906 1 0 09000064b9268328
FDA-2026-N-2431-0001 FDA FDA-2026-N-2431 Agency Information Collection Activities; Proposed Collection; Comment Request; Administrative Practices and Procedures; Formal Hearings Notice 60 Day Proposed Information Collection 2026-04-07 2026 4 2026-04-07 2026-06-09 2026-05-12 09:00:14 2026-06719 1 0 09000064b9255485
FDA-2025-E-0863-0006 FDA FDA-2025-E-0863 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:37:03 2026-06478 1 0 09000064b924cccb
FDA-2025-E-0845-0006 FDA FDA-2025-E-0845 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:34:01 2026-06478 1 0 09000064b924dac3
FDA-2025-E-0866-0006 FDA FDA-2025-E-0866 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:42:13 2026-06478 1 0 09000064b924ccce
FDA-2025-E-0372-0005 FDA FDA-2025-E-0372 Determination of Regulatory Review Period for Purposes of Patent Extension; ZIIHERA Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:52:42 2026-06476 1 0 09000064b924da88
FDA-2025-E-3074-0006 FDA FDA-2025-E-3074 Determination of Regulatory Review Period for Purposes of Patent Extension; EMRELIS Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:57:30 2026-06480 1 0 09000064b924c470
FDA-2025-E-0871-0006 FDA FDA-2025-E-0871 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:49:10 2026-06478 1 0 09000064b924c46e
FDA-2025-E-3073-0006 FDA FDA-2025-E-3073 Determination of Regulatory Review Period for Purposes of Patent Extension; EMRELIS Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:55:54 2026-06480 1 0 09000064b924da86
FDA-2025-E-3626-0006 FDA FDA-2025-E-3626 Determination of Regulatory Review Period for Purposes of Patent Extension; ENFLONSIA Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:59:57 2026-06479 1 0 09000064b924d98d
FDA-2025-E-0870-0006 FDA FDA-2025-E-0870 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:48:07 2026-06478 1 0 09000064b924c46d
FDA-2026-N-2740-0001 FDA FDA-2026-N-2740 Agency Information Collection Activities; Proposed Collection; Comment Request; Customer/Partner Customer Service Satisfaction Surveys Notice 60 Day Proposed Information Collection 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:29:44 2026-06482 1 0 09000064b924dac4
FDA-2025-E-0868-0006 FDA FDA-2025-E-0868 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:44:23 2026-06478 1 0 09000064b924c0e1
FDA-2025-E-0865-0006 FDA FDA-2025-E-0865 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:39:45 2026-06478 1 0 09000064b924cccd
FDA-2025-E-1672-0007 FDA FDA-2025-E-1672 Determination of Regulatory Review Period for Purposes of Patent Extension; ENCELTO Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 18:06:28 2026-06477 1 0 09000064b924d940
FDA-2014-E-2328-0006 FDA FDA-2014-E-2328 Determination of Regulatory Review Period for Purposes of Patent Extension; INJECTAFER Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 18:09:13 2026-06483 1 0 09000064b924d4f5
FDA-2025-E-0864-0006 FDA FDA-2025-E-0864 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:38:27 2026-06478 1 0 09000064b924cccc
FDA-2025-E-0872-0006 FDA FDA-2025-E-0872 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:50:02 2026-06478 1 0 09000064b924c46f
FDA-2025-E-0158-0006 FDA FDA-2025-E-0158 Determination of Regulatory Review Period for Purposes of Patent Extension; HYMPAVZI Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 18:04:00 2026-06481 1 0 09000064b924d942
FDA-2025-E-0867-0006 FDA FDA-2025-E-0867 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:43:31 2026-06478 1 0 09000064b924c0e0
FDA-2025-E-0869-0006 FDA FDA-2025-E-0869 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:45:32 2026-06478 1 0 09000064b924ba07
FDA-2026-N-0499-0002 FDA FDA-2026-N-0499 Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Hazard Analysis and Critical Control Point Procedures for the Safe and Sanitary Processing and Importing of Juice Notice 30 Day Proposed Information Collection 2026-04-30 2026 4 2026-04-30 2026-06-02 2026-04-30 17:46:42 2026-08417 1 0 09000064b92b80f2
FDA-2026-C-3071-0001 FDA FDA-2026-C-3071 Filing of Color Additive Petition: International Association of Color Manufacturers; Request to Amend the Color Additive Regulations to Remove the Solvents Methylene Chloride, Trichloroethylene, and Ethylene Dichloride Proposed Rule Petition 2026-04-01 2026 4 2026-04-01 2026-06-02 2026-04-01 17:16:12 2026-06295 1 0 09000064b9249960
FDA-2026-N-0809-0001 FDA FDA-2026-N-0809 Recommendations on Scale-Up and Postapproval Changes Guidances for Industry; Request for Comments Notice Request for Comments 2026-03-03 2026 3 2026-03-03 2026-06-02 2026-05-07 09:00:19 2026-04196 1 0 09000064b91ed501
FDA-2026-N-2476-0001 FDA FDA-2026-N-2476 Advancing the Use of Digital Health Technologies in Clinical Investigations for Drugs and Biological Products; Request for Information and Comments Notice Request for Comments 2026-03-31 2026 3 2026-03-31 2026-06-02 2026-05-17 09:00:21 2026-06184 1 0 09000064b92439d6
FDA-2026-N-4390-0001 FDA FDA-2026-N-4390 AI-Enabled Optimization of Early- Phase Clinical Trials Pilot Program; Request for Information Notice Requests for Information (RFI) 2026-04-29 2026 4 2026-04-29 2026-05-30 2026-05-17 09:00:24 2026-08281 1 0 09000064b92b54c8
FDA-2026-N-2590-0001 FDA FDA-2026-N-2590 Microbiology Devices; Reclassification of Mycobacterium Tuberculosis Cell-Mediated Immunity Tests and Immune Response Enzyme-Linked Immunospot Tests Proposed Rule Request for Comment 2026-03-30 2026 3 2026-03-30 2026-05-30 2026-05-13 09:00:24 2026-06064 1 0 09000064b92437b6
FDA-2026-N-3962-0001 FDA FDA-2026-N-3962 Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments— United States (U.S.) 2026–2027 Formula for COVID–19 Vaccine Composition Notice Request for Comments 2026-04-27 2026 4 2026-04-27 2026-05-28 2026-05-17 09:00:24 2026-08122 1 0 09000064b92ad21d
FDA-2026-N-2642-0001 FDA FDA-2026-N-2642 Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke; Established List Additions and Request for Comments Notice Request for Comments 2026-04-23 2026 4 2026-04-23 2026-05-27 2026-05-16 09:00:16 2026-07910 1 0 09000064b92a4e3b
FDA-2024-E-5140-0006 FDA FDA-2024-E-5140 Determination of Regulatory Review Period for Purposes of Patent Extension; ENVISION MAMMOGRAPHY PLATFORM Notice Determinations 2025-11-24 2025 11 2025-11-24 2026-05-27 2026-01-24 13:16:48 2025-20667 1 0 09000064b908e3f0
FDA-2024-E-5139-0006 FDA FDA-2024-E-5139 Determination of Regulatory Review Period for Purposes of Patent Extension; ENVISION MAMMOGRAPHY PLATFORM Notice Determinations 2025-11-24 2025 11 2025-11-24 2026-05-27 2026-01-24 13:16:48 2025-20667 1 0 09000064b908e3ef
FDA-2024-E-5141-0006 FDA FDA-2024-E-5141 Determination of Regulatory Review Period for Purposes of Patent Extension; ENVISION MAMMOGRAPHY PLATFORM Notice Determinations 2025-11-24 2025 11 2025-11-24 2026-05-27 2026-01-24 13:16:50 2025-20667 1 0 09000064b9092f99
FDA-2024-E-5681-0006 FDA FDA-2024-E-5681 Determination of Regulatory Review Period for Purposes of Patent Extension; ALTIUS DIRECT ELECTRICAL NERVE STIMULATION SYSTEM Notice Determinations 2025-11-24 2025 11 2025-11-24 2026-05-27 2025-11-24 19:32:14 2025-20668 1 0 09000064b9093521
FDA-2026-N-2365-0001 FDA FDA-2026-N-2365 Agency Information Collection Activities; Proposed Collection; Comment Request; Reporting Associated With Animal Drug and Animal Generic Drug User Fees Notice 60 Day Proposed Information Collection 2026-03-23 2026 3 2026-03-23 2026-05-23 2026-03-23 17:37:47 2026-05620 1 0 09000064b922c25e
FDA-2026-N-2364-0001 FDA FDA-2026-N-2364 Agency Information Collection Activities; Proposed Collection; Comment Request; Food and Drug Administration Advisory Committees Notice 60 Day Proposed Information Collection 2026-03-23 2026 3 2026-03-23 2026-05-23 2026-03-25 09:00:29 2026-05623 1 0 09000064b922c187
FDA-2025-D-2837-0002 FDA FDA-2025-D-2837 Questions and Answers About Requirements for Additional Traceability Records for Certain Foods: Guidance for Industry - Draft Guidance Other Guidance 2026-02-20 2026 2 2026-02-20 2026-05-22 2026-02-20 20:47:16   1 0 09000064b91c9d9a
FDA-2026-N-1304-0001 FDA FDA-2026-N-1304 Agenda for the U.S. Food and Drug Administration (FDA) Virtual Public Meeting Food Allergen Thresholds and Their Potential Applications 2-18-2026 Other Agenda 2026-02-18 2026 2 2026-02-18 2026-05-20 2026-05-17 09:00:21   1 0 09000064b91b5eeb
FDA-2025-N-5995-0001 FDA FDA-2025-N-5995 Effective Date of Requirement for Premarket Approval Applications for Blood Irradiators Intended To Prevent Metastasis Proposed Rule Notice of Proposed Rulemaking (NPRM) 2026-03-18 2026 3 2026-03-18 2026-05-19 2026-03-21 09:00:16 2026-05322 1 0 09000064b92215cb
FDA-2025-N-5996-0001 FDA FDA-2025-N-5996 Medical Devices; Radiology Devices; Classification of Blood Irradiators Proposed Rule Notice of Proposed Rulemaking (NPRM) 2026-03-18 2026 3 2026-03-18 2026-05-19 2026-05-07 09:00:21 2026-05320 1 0 09000064b92216a5
FDA-2026-N-1849-0001 FDA FDA-2026-N-1849 Agency Information Collection Activities; Proposed Collection; Comment Request; Premarket Notifications Submission Notice 60 Day Proposed Information Collection 2026-03-19 2026 3 2026-03-19 2026-05-19 2026-03-19 17:24:48 2026-05329 1 0 09000064b9224334
FDA-2026-N-2279-0001 FDA FDA-2026-N-2279 Preparation for International Cooperation on Cosmetics Regulation Twentieth Annual Meeting (ICCR–20); Request for Comments Notice Request for Comments 2026-03-18 2026 3 2026-03-18 2026-05-19 2026-05-12 09:00:12 2026-05280 1 0 09000064b922165c
FDA-2025-D-6131-0002 FDA FDA-2025-D-6131 General Considerations for the Use of New Approach Methodologies in Drug Development; Guidance for Industry - Draft Guidance Other Guidance 2026-03-19 2026 3 2026-03-19 2026-05-19 2026-05-16 09:00:11   1 0 09000064b9223609

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
            id TEXT PRIMARY KEY,
            agency_id TEXT,
            docket_id TEXT,
            title TEXT,
            document_type TEXT,
            subtype TEXT,
            posted_date TEXT,
            posted_year INTEGER,
            posted_month INTEGER,
            comment_start_date TEXT,
            comment_end_date TEXT,
            last_modified TEXT,
            fr_doc_num TEXT,
            open_for_comment INTEGER,
            withdrawn INTEGER,
            object_id TEXT
        );
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date);
CREATE INDEX idx_docs_withdrawn ON documents(withdrawn);
Powered by Datasette · Queries took 9.172ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API